Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal
Status and phase
Conditions
Treatments
Details and patient eligibility
About
Assured treatment with Risperal CONSTA will provide first-episode patients, who have a greater potential for therapeutic response, with their best opportunity for continued improvement in cognitive function beyond three months of treatment.
Full description
First episode patients have a greater potential for therapeutic response than multi-episode patients, and many of them also havea great desire to rejoin the workforce. Unfortunately, first episode patients become non-compliant or intermittently compliant with prescribed antipsychotic treatment at least as frequently as multi-episode patients. We believe that assured treatment with Risperal CONTSTA will provide first episode patients wiwth their best opporutnity for continued improvement in cognitive function beyond 3 months of treatment and that improvements in cognitive function will be associated with a greater likelihood of employment, real-world outcomes, such as independent living, as well as measures of brain function.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- male or female between 18-40 years of age
- meet DSM-IV criteria for first-episode schizophreniform, schizophrenia or schizoaffective disorder
Exclusion criteria
- pregnant & breast-feeding women
- patients with known sensitivity to oral Risperdal
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal